BioSyent Inc. - Net Worth and Insider Trading
BioSyent Inc. Net Worth
The estimated net worth of BioSyent Inc. is at least $2 Million dollars as of 2024-11-09. BioSyent Inc. is the Issuer of Biosyent Inc and owns about 201,500 shares of Biosyent Inc (TSXV:RX) stock worth over $2 Million. Details can be seen in BioSyent Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that BioSyent Inc. has not made any transactions after 2021-08-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of BioSyent Inc.
BioSyent Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, BioSyent Inc. owns 1 companies in total, including Biosyent Inc (TSXV:RX) .
Click here to see the complete history of BioSyent Inc.’s form 4 insider trades.
Insider Ownership Summary of BioSyent Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:RX | Biosyent Inc | 2021-08-06 | Issuer |
BioSyent Inc. Latest Holdings Summary
BioSyent Inc. currently owns a total of 1 stock. BioSyent Inc. owns 201,500 shares of Biosyent Inc (TSXV:RX) as of August 6, 2021, with a value of $2 Million.
Latest Holdings of BioSyent Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:RX | Biosyent Inc | 2021-08-06 | 201,500 | 11.15 | 2,246,725 |
Holding Weightings of BioSyent Inc.
BioSyent Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, BioSyent Inc. has made a total of 2 transactions in Biosyent Inc (TSXV:RX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Biosyent Inc is the acquisition of 6,700 shares on August 6, 2021, which cost BioSyent Inc. around $50,317.
Insider Trading History of BioSyent Inc.
- 1
BioSyent Inc. Trading Performance
GuruFocus tracks the stock performance after each of BioSyent Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by BioSyent Inc. is -15.36%. GuruFocus also compares BioSyent Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by BioSyent Inc. within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how BioSyent Inc.'s insider trading performs compared to the benchmark.
Performance of BioSyent Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.71 | | | | | |
| Relative Return to S&P 500(%) | -11.53 | | | | | |
BioSyent Inc. Ownership Network
Ownership Network List of BioSyent Inc.
Ownership Network Relation of BioSyent Inc.
BioSyent Inc. Owned Company Details
What does Biosyent Inc do?
Who are the key executives at Biosyent Inc?
BioSyent Inc. is the Issuer of Biosyent Inc. Other key executives at Biosyent Inc include Senior Officer Sharan Raghubir , 10% Security Holder & Director & Senior Officer Rene Goehrum , and Senior Officer Joost van der Mark .
Biosyent Inc (TSXV:RX) Insider Trades Summary
Over the past 18 months, BioSyent Inc. made no insider transaction in Biosyent Inc (TSXV:RX). Other recent insider transactions involving Biosyent Inc (TSXV:RX) include a net sale of 6,304 shares made by Seyed Ahmad Ashrafi , a net sale of 5,505 shares made by Sharan Raghubir , and a net sale of 1,235 shares made by Peter Douglas Lockhard .
In summary, during the past 3 months, insiders sold 5,939 shares of Biosyent Inc (TSXV:RX) in total and bought 0 shares, with a net sale of 5,939 shares. During the past 18 months, 14,566 shares of Biosyent Inc (TSXV:RX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,566 shares.
Biosyent Inc (TSXV:RX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biosyent Inc Insider Transactions
BioSyent Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for BioSyent Inc.. Currently GuruFocus does not have mailing address information for BioSyent Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
